Skip to content
October 11, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Patient Advocacy and Support
  • Navigating the Survivorship Gap: Breast Cancer Canada Announces Comprehensive Post-Treatment Webinar Series for October 2026
  • Patient Advocacy and Support

Navigating the Survivorship Gap: Breast Cancer Canada Announces Comprehensive Post-Treatment Webinar Series for October 2026

Asep Darmawan October 10, 2026 7 minutes read
navigating-the-survivorship-gap-breast-cancer-canada-announces-comprehensive-post-treatment-webinar-series-for-october-2026

TORONTO, ON – As the medical community continues to make strides in early detection and targeted therapies, the number of breast cancer survivors worldwide is reaching unprecedented levels. However, the transition from active clinical treatment to long-term survivorship remains one of the most challenging phases of the patient journey. Recognizing this "survivorship gap," Breast Cancer Canada (BCC) has announced a high-impact webinar series scheduled for October 2026.

The series, titled "Life Beyond Treatment," features a multidisciplinary panel of experts, including registered dietitians, advocates, and wellness founders. By addressing the nutritional, physical, and emotional complexities that persist long after the final round of chemotherapy or radiation, BCC aims to empower survivors with evidence-based strategies for a high-quality life.


Main Facts: Addressing the "New Normal" in Breast Cancer Care

The transition out of active treatment is often referred to by patients as "falling off a cliff." During treatment, patients are monitored closely by oncology teams; once treatment concludes, they are often left to navigate a "new normal" characterized by lingering side effects, fear of recurrence, and significant physical changes.

Breast Cancer Canada’s 2026 series is designed to provide a roadmap for this transition. The program is structured into three primary pillars:

  1. Nutritional Resilience: Led by Jean LaMantia, RD, focusing on metabolic health and bone density.
  2. Physical Recovery: Led by Voula Pantelis, focusing on lymphedema management and body image.
  3. Emotional Integration: Led by Jacqueline Beatty, focusing on the psychological "Root to Rise" framework.

Each session is scheduled for Thursdays throughout October, coinciding with Breast Cancer Awareness Month, and will be hosted via a digital platform to ensure national accessibility for patients, caregivers, and healthcare professionals alike.


Chronology: The October 2026 Webinar Schedule

The series is meticulously timed to guide participants through a logical progression of recovery, starting with internal health, moving to external physical maintenance, and concluding with internal psychological healing.

October 8, 2026: Evidence-Based Nutrition and Metabolic Health

Speaker: Jean LaMantia, RD, Registered Dietitian and Cancer Survivor

The series kicks off with a deep dive into the often-confusing world of oncology nutrition. Jean LaMantia, a renowned expert who blends professional expertise with the lived experience of survivorship, will address the critical need for protein and muscle maintenance.

For many patients, endocrine therapy (such as aromatase inhibitors) can lead to bone density loss and weight fluctuations. LaMantia’s session aims to demystify these changes, offering practical meal-building strategies that avoid the "restrictive dieting" trap which often fuels anxiety. Key topics include:

  • Maintaining lean muscle mass to combat cancer-related fatigue.
  • The role of gut health in long-term immunity.
  • Managing the fear of recurrence through balanced eating rather than "superfood" myths.

October 15, 2026: Managing the Physical Lasting Effects

Speaker: Voula Pantelis, Breast Cancer Advocate and General Manager, AMOENA Canada

The second installment shifts focus to the tangible, physical changes that occur post-surgery and post-treatment. Voula Pantelis brings her extensive experience in post-mastectomy care to discuss the management of scars, lymphedema, and the return to physical activity.

This session is particularly vital for survivors dealing with the "hidden" side effects of surgery, such as restricted range of motion or chronic discomfort. Pantelis will provide insights into:

  • Effective scar management and compression therapy.
  • Navigating lymphedema risks during travel and daily life.
  • Re-establishing a positive body image after significant physical alteration.

October 22, 2026: Emotional Transitions and the "Root to Rise" Framework

Speaker: Jacqueline Beatty, Breast Cancer Survivor and Founder, Rising Lotus

The final session addresses the psychological architecture of survivorship. Jacqueline Beatty introduces her "Root to Rise" framework, which focuses on emotional regulation and identity reclamation.

As survivors return to work and social routines, they often find that their priorities have shifted. Beatty’s session focuses on:

  • Navigating the "identity crisis" that follows a cancer diagnosis.
  • Setting boundaries in professional and personal relationships.
  • Reconnecting with personal values to build a post-cancer life that feels authentic and purposeful.

Supporting Data: The Rising Need for Survivorship Support

The necessity of this webinar series is underscored by current oncology statistics. According to data from the Canadian Cancer Society and international research bodies, the five-year net survival rate for breast cancer is now approximately 89%. While this is a triumph of modern medicine, it has created a massive demographic of survivors living with chronic side effects.

The Nutritional and Metabolic Burden

Research indicates that up to 60% of breast cancer survivors experience significant weight gain during treatment, which is linked to an increased risk of recurrence and other metabolic disorders. Furthermore, muscle wasting (sarcopenia) is a common side effect of chemotherapy, making Jean LaMantia’s focus on protein intake and muscle maintenance a clinical priority.

The Lymphedema and Physical Reality

Lymphedema—the swelling of the arm or chest due to lymph node removal or damage—affects an estimated 20% to 30% of breast cancer survivors. Without proper education on compression and movement, this condition can become debilitating. The session by Voula Pantelis addresses a critical gap in patient education regarding long-term lymphatic health.

The Psychological Impact

Studies on post-cancer "re-entry" suggest that nearly 40% of survivors report symptoms of anxiety or depression in the first year following the end of active treatment. The "fear of recurrence" (FCR) is cited as the most common psychological concern, affecting nearly 90% of survivors to some degree. Jacqueline Beatty’s "Root to Rise" framework targets these specific psychological stressors.


Official Responses and Expert Perspectives

Breast Cancer Canada has emphasized that this series is part of a broader shift toward "integrative survivorship," where the goal is not just the absence of disease, but the presence of wellness.

Jean LaMantia, RD, commented on the importance of evidence-based clarity:
"The internet is a minefield of misinformation for cancer survivors. My goal for this session is to strip away the fear-based marketing of ‘miracle diets’ and provide survivors with the scientific tools they need to nourish their bodies and reclaim their health."

Voula Pantelis, representing the physical advocacy side, noted:
"Treatment may end, but the body remembers. We need to provide survivors with the grace and the gear—whether it’s compression sleeves or scar care—to move through the world with confidence again."

Jacqueline Beatty, speaking on the emotional component, stated:
"Survival is the first step, but ‘rising’ is the second. We focus on the Root to Rise framework because it allows survivors to ground themselves in their new reality before they attempt to branch out into their old lives."


Implications: The Future of Survivorship Care

The 2026 webinar series represents a significant evolution in how advocacy groups approach cancer care. By providing these resources for free, Breast Cancer Canada is democratizing access to high-level specialist knowledge that is often only available in major metropolitan cancer centers.

Bridging the Rural-Urban Divide

By hosting these sessions digitally, BCC ensures that survivors in rural or underserved areas have access to the same quality of nutritional and emotional support as those in urban centers. This is a crucial step in addressing health equity within the Canadian oncology landscape.

Empowering the "Expert Patient"

This series reflects the rise of the "expert patient"—individuals who are not just passive recipients of care but active participants in their recovery. By educating survivors on the nuances of bone health, lymphatic drainage, and emotional regulation, BCC is reducing the long-term burden on the primary healthcare system.

A Model for Other Cancers

The success of this structured, pillar-based approach to survivorship could serve as a blueprint for other advocacy groups. Whether dealing with prostate, lung, or colorectal cancer, the "survivorship gap" is a universal challenge in modern medicine. BCC’s proactive 2026 schedule highlights a future where the end of treatment is not the end of care, but the beginning of a supported, healthy life.

As October 2026 approaches, Breast Cancer Canada encourages survivors, family members, and healthcare providers to register for these sessions. In a world where a diagnosis is no longer a life sentence, the focus must shift to ensuring that the life saved is a life well-lived.


For more information on the "Life Beyond Treatment" series or to register for the upcoming sessions, visit the Breast Cancer Canada official website.

About the Author

Asep Darmawan

Author

View All Posts

Post navigation

Previous: Bridging Compassion and Care: WHO Director-General’s State Visit to Jordan Highlights Global Health Resilience
Next: FDA Expands First-Line Maintenance Options for HER2-Positive Metastatic Breast Cancer: A New Era of Targeted Triple Therapy

Related Stories

navigating-the-intersection-of-glp-1-medications-and-breast-cancer-a-deep-dive-into-emerging-research
  • Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Deep Dive into Emerging Research

Jia Lissa October 10, 2026
global-landmarks-to-glow-teal-green-and-pink-the-2026-push-to-fund-metastatic-breast-cancer-research
  • Patient Advocacy and Support

Global Landmarks to Glow Teal, Green, and Pink: The 2026 Push to Fund Metastatic Breast Cancer Research

Nana October 10, 2026
Set iv fluid intravenous drop saline drip hospital room,Medical Concept,treatment emergency and injection drug infusion care chemotherapy, concept.blue light background,selective focus stock photo
  • Patient Advocacy and Support

FDA Expands First-Line Maintenance Options for HER2-Positive Metastatic Breast Cancer: A New Era of Targeted Triple Therapy

Iffa Jayyana October 10, 2026

Recent Posts

  • Unmasking Cancer’s Master Manipulator: OU Research Reveals How Aggressive Breast Tumors Hijack the Immune System to Fuel Growth
  • Alumis Poised to Enter Crowded Psoriasis Market with Promising TYK2 Inhibitor, Envudeucitinib
  • Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Deep Dive into Emerging Research
  • Global Landmarks to Glow Teal, Green, and Pink: The 2026 Push to Fund Metastatic Breast Cancer Research
  • FDA Expands First-Line Maintenance Options for HER2-Positive Metastatic Breast Cancer: A New Era of Targeted Triple Therapy

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

unmasking-cancers-master-manipulator-ou-research-reveals-how-aggressive-breast-tumors-hijack-the-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Unmasking Cancer’s Master Manipulator: OU Research Reveals How Aggressive Breast Tumors Hijack the Immune System to Fuel Growth

Evan Lee Salim October 10, 2026
alumis-poised-to-enter-crowded-psoriasis-market-with-promising-tyk2-inhibitor-envudeucitinib
  • Medical Research and Clinical Trials

Alumis Poised to Enter Crowded Psoriasis Market with Promising TYK2 Inhibitor, Envudeucitinib

Nana Wu October 10, 2026
navigating-the-intersection-of-glp-1-medications-and-breast-cancer-a-deep-dive-into-emerging-research
  • Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Deep Dive into Emerging Research

Jia Lissa October 10, 2026
global-landmarks-to-glow-teal-green-and-pink-the-2026-push-to-fund-metastatic-breast-cancer-research
  • Patient Advocacy and Support

Global Landmarks to Glow Teal, Green, and Pink: The 2026 Push to Fund Metastatic Breast Cancer Research

Nana October 10, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.